Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.41B |
| 2 |
American Tower
AMT
|
+$272M |
| 3 |
Microsoft
MSFT
|
+$271M |
| 4 |
Zoom
ZM
|
+$245M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$206M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$200M |
| 3 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$186M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$151M |
| 5 |
Pfizer
PFE
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.25% |
| 2 | Healthcare | 13.6% |
| 3 | Financials | 13.05% |
| 4 | Consumer Discretionary | 12.39% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCON
3426
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $803K | ﹤0.01% |
+3,434
| New | +$478K |
|
3427
Plumas Bancorp
PLBC
$423M
| $801K | ﹤0.01% |
34,090
+218
| +0.6% | +$4.88K |
|
|
PSTL
3428
Postal Realty Trust
PSTL
$696M
| $801K | ﹤0.01% |
47,511
+3,406
| +8% | +$52.8K |
|
3429
SandRidge Energy
SD
$500M
| $797K | ﹤0.01% |
257,535
+3,331
| +1% | +$8.17K |
|
|
BIOR
3430
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $796K | ﹤0.01% |
600
+375
| +167% | +$550K |
|
3431
IBEX
IBEX
$485M
| $794K | ﹤0.01% |
42,471
+3,057
| +8% | +$54.4K |
|
|
SOLY
3432
DELISTED
Soliton, Inc.
SOLY
| $792K | ﹤0.01% |
103,143
+7,215
| +8% | +$59.3K |
|
|
SUP
3433
DELISTED
Superior Industries International
SUP
| $791K | ﹤0.01% |
193,731
+2,240
| +1% | +$6.98K |
|
3434
Value Line
VALU
$331M
| $789K | ﹤0.01% |
23,951
+57
| +0.2% | +$1.63K |
|
3435
Philips
PHG
$25.9B
| $784K | ﹤0.01% |
17,850
+223
| +1% | +$9.21K |
|
|
CSLT
3436
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $783K | ﹤0.01% |
603,677
+8,384
| +1% | +$9.43K |
|
|
LYRA
3437
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $781K | ﹤0.01% |
1,370
+560
| +69% | +$316K |
|
|
PHAS
3438
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $779K | ﹤0.01% |
232,036
-4,156
| -2% | -$14.9K |
|
3439
Actinium Pharmaceuticals
ATNM
$25.4M
| $778K | ﹤0.01% |
99,806
| – | – |
|
|
MITT
3440
TPG Mortgage Investment Trust
MITT
$227M
| $775K | ﹤0.01% |
87,639
+687
| +0.8% | +$6.15K |
|
3441
Reading International Class A
RDI
$32.3M
| $775K | ﹤0.01% |
154,492
+7,403
| +5% | +$25.8K |
|
3442
TETRA Technologies
TTI
$1.28B
| $775K | ﹤0.01% |
900,529
-383
| -0% | -$263 |
|
3443
Smith & Nephew
SNN
$12.8B
| $772K | ﹤0.01% |
18,312
+320
| +2% | +$12.7K |
|
3444
Babcock & Wilcox
BW
$1.51B
| $767K | ﹤0.01% |
218,660
+7,043
| +3% | +$22.1K |
|
|
SAL
3445
DELISTED
Salisbury Bancorp, Inc.
SAL
| $764K | ﹤0.01% |
41,040
+312
| +0.8% | +$5.78K |
|
3446
Marker Therapeutics
MRKR
$20.5M
| $762K | ﹤0.01% |
52,587
+1,820
| +4% | +$28.3K |
|
3447
Inspired Entertainment
INSE
$183M
| $761K | ﹤0.01% |
115,682
| – | – |
|
3448
Innodata
INOD
$2.29B
| $759K | ﹤0.01% |
143,375
+54,611
| +62% | +$217K |
|
3449
Identive
INVE
$64.3M
| $758K | ﹤0.01% |
89,245
+6,073
| +7% | +$41.8K |
|
|
AIFU
3450
AIFU Inc
AIFU
$220M
| $753K | ﹤0.01% |
156
+12
| +8% | +$70.6K |
|
Similar funds
Geode Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Geode Capital Management held 4,369 positions worth $596B, up 17% from $510B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q4 2020 filing shows 215 new, 3,067 increased, 650 reduced and 100 closed positions. Its largest new stake was Apartment Income REIT Corp.: 2,223,585 shares worth $85.4M. The largest sale was Tiffany & Co., an estimated $206M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,223,585 shares worth $85.4M.
- Geode Capital Management added most to Tesla in Q4 2020, an estimated $2.41B increase.
- Geode Capital Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $131M.
- Geode Capital Management fully exited Tiffany & Co. in Q4 2020, selling an estimated $206M.
- Geode Capital Management's ten largest holdings make up 22% of its $596B portfolio in Q4 2020.
- Geode Capital Management opened 215 new positions and closed 100 in Q4 2020.
- Geode Capital Management's portfolio value rose 17% quarter-over-quarter to $596B.
Based on Geode Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.